alexa The Impact of Personalized Medicine on Pharmacovigilance

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The Impact of Personalized Medicine on Pharmacovigilance

As we all know, the field of pharmacovigilance has grown enormously in recent years. Some of this was caused by normal expansion at pharmaceutical companies and at biotechnology firms through the addition of new products and in pioneering fields. Perhaps the most compelling source of growth in the pharmacovigilance area has been through FDA requirements regarding the reporting of adverse events and other unexpected outcomes. There are many persons who see a continuing increase in the importance and size, especially in headcount, for a pharmacovigilance component of these companies. However, there is some reason to believe that new developments in the area of personalized medicine may change much of that expected progression. If we step back and think about the causes of adverse events and other untoward reactions to medications, we find that many of these are due to various metabolic pathways that differ both in group populations as well as within individuals.

Citation: Wertheimer A (2015) The Impact of Personalized Medicine on Pharmacovigilance. J Pharmacovigilance 3:e133. doi: 10.4172/2329-6887.1000e133

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger